Trade Summary

2 months ago, HALBERT JON, serving as Dir at Caris Life Sciences, Inc. (CAI), purchased 68,000 shares at $14.56 per share, for a total transaction value of $990,080.00. Following this transaction, HALBERT JON now holds 704,598 shares of CAI.

This purchase represents a 10.68% increase in HALBERT JON's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 15, 2026 and publicly disclosed via SEC Form 4 filing on Monday, July 13, 2026 at 7:06 AM ET, 59 days after the trade was made.

Caris Life Sciences, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.